← back to search

Kenar D. Jhaveri

NewYork–Presbyterian Hospital ·
Area of research
Nephrology · Transplantation
Research interest
Research interests include Medicine, Acute kidney injury, Internal medicine, Cancer, Kidney transplant, and Kidney.
h-index
citations
1,116
works
18
NIH funding
primary concept
email

Recent publications

Intravenous Magnesium and Cisplatin-Associated Acute Kidney Injury
JAMA Oncology 2025cited by 23position: middledoi
Kidney transplant in patients with C3 glomerulopathy
Clinical Kidney Journal 2025cited by 8position: lastdoi
Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study
BMJ 2024cited by 34position: middledoi
Similar Risk of Kidney Failure among Patients with Blinding Diseases Who Receive Ranibizumab, Aflibercept, and Bevacizumab
Ophthalmology Retina 2024cited by 15position: middledoi
Primary IgA Nephropathy: New Insights and Emerging Therapies
Advances in Kidney Disease and Health 2024cited by 12position: middledoi
Lupus nephritis: management challenges during pregnancy
Frontiers in Nephrology 2024cited by 5position: middledoi
Improving Cancer Care for Patients With CKD: The Need for Changes in Clinical Trials
Kidney International Reports 2022cited by 23position: lastdoi
COVID-19 Vaccination and New Onset Glomerular Disease: Results from the IRocGN2 International Registry
Kidney360 2022cited by 18position: middledoi
Acute kidney injury in patients treated with immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer 2021cited by 222position: middledoi
Immune checkpoint inhibitor use in patients with end-stage kidney disease: an analysis of reported cases and literature review
Clinical Kidney Journal 2021cited by 45position: middledoi
Kidney injury and disease in patients with haematological malignancies
Nature Reviews Nephrology 2021cited by 39position: middledoi
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant
Kidney International 2020cited by 176position: lastdoi
A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease
Kidney International Reports 2020cited by 147position: middledoi
Remdesivir in Patients With Estimated GFR <30 ml/min per 1.73 m2 or on Renal Replacement Therapy
Kidney International Reports 2020cited by 27position: middledoi
Improving Cancer Care for Patients With Chronic Kidney Disease
Journal of Clinical Oncology 2019cited by 16position: middledoi
Renal pathology practice globally: identifying needs and meeting the challenge
Kidney International 2019cited by 12position: lastdoi
Risk factors associated with post–kidney transplant malignancies: an article from the Cancer-Kidney International Network
Clinical Kidney Journal 2017cited by 156position: lastdoi
Why Not Nephrology? A Survey of US Internal Medicine Subspecialty Fellows
American Journal of Kidney Diseases 2013cited by 138position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Ben Sprangers · KU Leuven4 papers (2017–2022)Jamie S. Hirsch · Northwell Health3 papers (2020–2025)Ilya Glezerman · Memorial Sloan Kettering Cancer Center3 papers (2021–2025)Rimda Wanchoo · Northwell Health3 papers (2020–2021)David E. Leaf · Brigham and Women's Hospital2 papers (2024–2025) · 2 papers (2024–2025) · 2 papers (2020–2021)Mark A. Perazella · Yale University2 papers (2019–2022)Ala Abudayyeh · The University of Texas Health Science Center at Houston2 papers (2024–2025)Meghan E. Sise · Columbia University2 papers (2020–2024)Shruti Gupta · Winship Cancer Institute2 papers (2024–2025) · 2 papers (2024–2025)Anip Bansal · University of Colorado System2 papers (2024–2025)Valda D. Page · The University of Texas Health Science Center at Houston2 papers (2024–2025) · 2 papers (2024–2025)Matthew Abramson · Memorial Sloan Kettering Cancer Center2 papers (2024–2025)Kammi Henriksen · University of Chicago1 papers (2020–2020) · 1 papers (2024–2024) · 1 papers (2020–2020) · 1 papers (2020–2020)